The chemical class designated as IRG1 Activators encompasses a diverse group of compounds that share the common function of inducing the expression of the immune-responsive gene 1 (IRG1) protein. These molecules are of particular interest due to their ability to engage with and modulate the immune system's metabolic pathways. IRG1 activators can be found in a variety of sources, including natural substances found in plants, synthetic compounds designed to mimic pathogenic components, and even metabolic byproducts. The primary unifying characteristic of these activators is their capacity to stimulate the cellular mechanisms that lead to the upregulation of IRG1, a key player in the immune response to environmental challenges. While their structures and origins are varied, the outcome of their interaction with immune cells converges on the enhancement of itaconate production, a metabolite significant for its role in immune cell function.
The mechanisms through which IRG1 activators exert their influence are multifaceted and interconnected with the core signaling pathways of immune cells. For instance, some activators function by mimicking the presence of pathogens, engaging toll-like receptors (TLRs) and triggering a defensive cellular response that includes the upregulation of IRG1. Others may interact with cellular pathways that control the transcriptional machinery, leading to increased expression of the IRG1 gene. The actions of these compounds are often associated with alterations in the cellular redox state, modulation of inflammatory responses, and the reprogramming of cellular metabolism. Despite the different molecular pathways they affect, IRG1 activators collectively contribute to the dynamic regulation of immune responses, illustrating the profound impact that small molecules can have on the complex network of immune regulation. Through their interaction with cellular processes, these activators provide valuable insights into the intricate balance between metabolic and immune system dynamics.
関連項目
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $96.00 $166.00 $459.00 $1615.00 | 12 | |
诱导巨噬细胞活化并随后产生细胞因子,从而导致 IRG1 上调。 | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
具有免疫调节作用,可激活 Nrf2 信号,从而可能影响 IRG1 的表达。 | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
调节 NF-κB 通路,该通路与多种免疫反应基因的表达有关,可能包括 IRG1。 | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $286.00 $806.00 $1510.00 | 1 | |
影响巨噬细胞的新陈代谢,具有抗炎作用,可间接上调 IRG1。 | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $154.00 $276.00 $506.00 $1154.00 $19743.00 $32136.00 $69366.00 | 1 | |
TLR7 激动剂可激活免疫反应,并可能上调 IRG1 作为该反应的一部分。 | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $66.00 $278.00 | 6 | |
TLR7/8 激动剂可激活先天性免疫反应,并可能增加 IRG1 的表达。 | ||||||
Pam3Cys-Ser-(Lys)4, Hydrochloride | 112208-00-1 | sc-507471 | 2 mg | $550.00 | ||
TLR1/2 激动剂可触发免疫细胞活化,从而可能导致 IRG1 表达增加。 |